Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$72.19
+1.3%
$64.59
$33.35
$83.31
$2.12B1.12508,423 shs273,939 shs
NovoCure Limited stock logo
NVCR
NovoCure
$17.96
+0.3%
$13.37
$9.82
$20.06
$2.08B0.91.79 million shs848,886 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$25.89
+1.3%
$22.02
$12.56
$27.98
$1.79B1.63333,306 shs250,573 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
$19.01
$535.71M2.17444,551 shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
+1.70%+2.05%+11.19%-6.28%+98.52%
NovoCure Limited stock logo
NVCR
NovoCure
+0.85%-0.83%+46.36%+57.57%+0.85%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-2.03%-5.68%+6.59%+19.33%+47.75%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+122.89%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$72.19
+1.3%
$64.59
$33.35
$83.31
$2.12B1.12508,423 shs273,939 shs
NovoCure Limited stock logo
NVCR
NovoCure
$17.96
+0.3%
$13.37
$9.82
$20.06
$2.08B0.91.79 million shs848,886 shs
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$25.89
+1.3%
$22.02
$12.56
$27.98
$1.79B1.63333,306 shs250,573 shs
ZimVie Inc. stock logo
ZIMV
ZimVie
$18.99
$18.96
$8.15
$19.01
$535.71M2.17444,551 shsN/A
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
+1.70%+2.05%+11.19%-6.28%+98.52%
NovoCure Limited stock logo
NVCR
NovoCure
+0.85%-0.83%+46.36%+57.57%+0.85%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-2.03%-5.68%+6.59%+19.33%+47.75%
ZimVie Inc. stock logo
ZIMV
ZimVie
0.00%0.00%0.00%0.00%+122.89%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
2.63
Moderate Buy$87.1420.71% Upside
NovoCure Limited stock logo
NVCR
NovoCure
2.38
Hold$27.2951.92% Upside
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
2.33
Hold$30.0015.87% Upside
ZimVie Inc. stock logo
ZIMV
ZimVie
1.67
Reduce$19.000.05% Upside

Current Analyst Ratings Breakdown

Latest ZIMV, NVCR, ESTA, and PLSE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/7/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Boost Price TargetBuy$88.00 ➝ $90.00
5/6/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Reiterated RatingNeutral
5/4/2026
NovoCure Limited stock logo
NVCR
NovoCure
Boost Price TargetEqual Weight$13.50 ➝ $17.00
5/1/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingOutperform
4/29/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Reiterated RatingBuy$88.00
4/21/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingSell (E+)
4/21/2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
Reiterated RatingSell (D-)
4/16/2026
NovoCure Limited stock logo
NVCR
NovoCure
Reiterated RatingNeutral$18.00
3/27/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Reiterated RatingSell (E+)
3/11/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Lower Price TargetNeutral$81.00 ➝ $74.00
2/26/2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
Boost Price TargetBuy$85.00 ➝ $90.00
(Data available from 5/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
$211.08M10.07N/AN/A$0.50 per share144.38
NovoCure Limited stock logo
NVCR
NovoCure
$655.35M3.17N/AN/A$2.86 per share6.28
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
$350K5,119.56N/AN/A$0.96 per share26.97
ZimVie Inc. stock logo
ZIMV
ZimVie
$449.75M1.19$1.86 per share10.22$13.83 per share1.37
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$51.06M-$1.49N/A515.64N/A-19.05%-218.77%-12.31%8/6/2026 (Estimated)
NovoCure Limited stock logo
NVCR
NovoCure
-$136.23M-$1.53N/AN/AN/A-25.66%-50.82%-16.48%7/23/2026 (Estimated)
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$72.78M-$1.10N/AN/AN/AN/A-86.67%-73.61%N/A
ZimVie Inc. stock logo
ZIMV
ZimVie
-$25.83M-$0.70N/AN/AN/A-4.39%6.37%3.34%N/A

Latest ZIMV, NVCR, ESTA, and PLSE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.3550-$0.45-$0.0951-$0.45$57.40 million$59.88 million
5/4/2026Q1 2026
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
-$0.32-$0.27+$0.05-$0.27$0.25 millionN/A
4/30/2026Q1 2026
NovoCure Limited stock logo
NVCR
NovoCure
-$0.5122-$0.62-$0.1078-$0.62$167.77 million$174.06 million
2/26/2026Q4 2025
NovoCure Limited stock logo
NVCR
NovoCure
-$0.41-$0.22+$0.19-$0.22$174.40 million$174.35 million
2/24/2026Q4 2025
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
-$0.22-$0.09+$0.13-$0.09$63.80 million$64.62 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
N/AN/AN/AN/AN/A
NovoCure Limited stock logo
NVCR
NovoCure
N/AN/AN/AN/AN/A
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/AN/AN/AN/AN/A
ZimVie Inc. stock logo
ZIMV
ZimVie
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
16.82
2.96
1.91
NovoCure Limited stock logo
NVCR
NovoCure
0.71
2.90
2.70
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
N/A
7.26
7.24
ZimVie Inc. stock logo
ZIMV
ZimVie
0.56
2.37
1.60

Institutional Ownership

CompanyInstitutional Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
72.91%
NovoCure Limited stock logo
NVCR
NovoCure
84.61%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
76.95%
ZimVie Inc. stock logo
ZIMV
ZimVie
95.63%

Insider Ownership

CompanyInsider Ownership
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
9.99%
NovoCure Limited stock logo
NVCR
NovoCure
5.52%
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
74.00%
ZimVie Inc. stock logo
ZIMV
ZimVie
5.41%
CompanyEmployeesShares OutstandingFree FloatOptionable
Establishment Labs Holdings Inc. stock logo
ESTA
Establishment Labs
1,00429.43 million26.49 millionOptionable
NovoCure Limited stock logo
NVCR
NovoCure
1,605115.82 million109.43 millionOptionable
Pulse Biosciences, Inc stock logo
PLSE
Pulse Biosciences
14069.21 million18.00 millionOptionable
ZimVie Inc. stock logo
ZIMV
ZimVie
1,77028.21 million26.69 millionNo Data

Recent News About These Companies

ZimVie Inc.
Inogen adds med tech vet to board
ZimVie Board Backs Year-End Transaction
ZimVie Inc Completes Acquisition by ARCHIMED
ZimVie Announces Completion of its Acquisition by ARCHIMED
Inside 4 orthopedic medtech splinters
ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED
ZimVie Inc Faces Legal Challenges Over Merger

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Establishment Labs stock logo

Establishment Labs NASDAQ:ESTA

$72.19 +0.96 (+1.35%)
Closing price 04:00 PM Eastern
Extended Trading
$72.19 0.00 (0.00%)
As of 07:03 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

NovoCure stock logo

NovoCure NASDAQ:NVCR

$17.96 +0.06 (+0.34%)
Closing price 04:00 PM Eastern
Extended Trading
$17.76 -0.20 (-1.12%)
As of 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Saint Helier, Jersey.

Pulse Biosciences stock logo

Pulse Biosciences NASDAQ:PLSE

$25.89 +0.33 (+1.29%)
Closing price 04:00 PM Eastern
Extended Trading
$25.88 -0.01 (-0.04%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

ZimVie stock logo

ZimVie NASDAQ:ZIMV

ZimVie Inc., together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment. The company offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; and patient-specific restorative solutions, such as abutments, bars, implant bridges, and hybrid restorations under the BellaTek brand name. It provides bone grafts, barrier membranes, and collagen wound care products; virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and intra-oral scanners; and Implant Concierge, a web-based treatment planning and surgery guide service. In addition, the company designs, manufactures, and distributes spinal fusion implants, instrumentation for various spinal procedures, biologics, and bone healing technologies. Further, it provides MIS solutions that deliver implant and instrumentation systems; and motion preservation solutions that offer non-fusion alternatives for cervical disc implant or growth modulation for anterior vertebral body tethering. The company sells its products to oral surgeons, dental specialists, general dentists, dental laboratories, and other dental organizations, including DSOs, as well as educational, medical, and governmental entities, hospitals, and surgery centers through direct sales representatives, agents, and distributors. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.